Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical AFX 5931 for Hand Dermatitis
NCT03703895Phase 4Completed
- Sponsor
- Center for Clinical and Cosmetic Research
- Start
- Sep 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of AFX-5931 in hand dermatitis (2 arms), sponsored by Center for Clinical and Cosmetic Research. Primary endpoints: Investigator's Global Assessment at Day 28 and Hand Eczema Severity Index at Day 28. Started Sep 2018; status: completed.
02
Drugs
AFX-5931
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on NCT03703895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03703895.